GlaxoSmithKline: Drisapersen fails in phase III

NEUTRAL, Fair Value 1870p vs. 1900p (+19%)

News published on September Monday 23, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities